Publication | Open Access

Dual knockdown of Galectin-8 and its glycosylated ligand, the activated leukocyte cell adhesion molecule (ALCAM/CD166), synergistically delays in vivo breast cancer growth

Dual KnockdownCell InteractionCell AdhesionImmunologyCell-matrix InteractionGlycosylated LigandMatrix BiologyMedicineCell BiologyCell SignalingTumor BiologyExtracellular Matrix